drugset / Trial / NCT00492128

Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

NCT00492128

Phase 4 Completed 196 enrolled Yokohama City University Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect and safety of the antihypertensive combination therapies between losartan/amlodipine and fixed dose drug of losartan/hydrochlorothiazide.

Timeline

Start
2007-09
Primary completion
2009-05
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Hydrochlorothiazide Unknown 12.5 mg
Background Losartan Other / unclassified 50 mg

Indications